NOVARTIS logo.jpg
Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.
January 26, 2021 01:00 ET | Novartis International AG
Full year net sales from continuing operations¹ up 3% (cc², +3% USD): Pharmaceuticals BU grew 5% (cc) driven by Entresto (+44% cc), Zolgensma (reaching USD 0.9 billion), Cosentyx (+13%...
NOVARTIS logo.jpg
En 2020, Novartis a enregistré une croissance de son chiffre d’affaires et de sa marge; il a continué de faire progresser sa prochaine vague de médicaments
January 26, 2021 01:00 ET | Novartis International AG
Chiffre d’affaires net des activités poursuivies1 en hausse de 3% (tcc2, +3% USD): Pharmaceuticals: cette unité opérationnelle a progressé de 5% (tcc), soutenue par Entresto...
LogistiCare Partners with Care Finders Total Care, LLC and Lyft to Create Unique Program Providing Critical Transportation Support for Home Health Aides
December 09, 2020 09:00 ET | LogistiCare
Denver, CO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- LogistiCare, the nation’s largest non-emergency medical transportation company and the contracted transportation vendor for New Jersey Medicaid...
NOVARTIS logo.jpg
Novartis im 3. Qu. mit solider Performance: operatives Kernergebnis steigt um 11%, Nettoumsatz auf Vorjahresniveau, starke Pipeline-Fortschritte; Jahresprognose für operatives Kernergebnis angehoben
October 27, 2020 02:00 ET | Novartis International AG
Im dritten Quartal 2020 lag der Nettoumsatz der fortzuführenden Geschäftsbereiche1 auf dem Niveau des Vorjahres (kWk2, +1% USD): Zu den Wachstumsträgern gehörten Entresto (USD 632 Millionen,...
NOVARTIS logo.jpg
Novartis au T3: performance solide, croissance de 11% du résultat opérationnel core, chiffre d’affaires net proche de l’an dernier, pipeline en fort progrès; hausse du résultat opérationnel core prévu
October 27, 2020 02:00 ET | Novartis International AG
Chiffre d’affaires net des activités poursuivies1 au T3 en ligne avec celui de l’exercice précédent (tcc2, +1% USD): Les moteurs de la croissance ont été notamment Entresto USD 632 millions (+45%...
NOVARTIS logo.jpg
Novartis delivers solid Q3 performance with 11% core operating income growth, net sales in line with prior year, strong pipeline progression. Upgrades full year core operating income guidance.
October 27, 2020 02:00 ET | Novartis International AG
Q3 net sales from continuing operations1 were in line with prior year (cc2, +1% USD): Growth drivers included Entresto USD 632 million (+45% cc), Zolgensma USD 291 million (+79% cc), Cosentyx USD 1...
NOVARTIS logo.jpg
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
September 16, 2020 10:24 ET | Novartis International AG
First healthcare industry sustainability-linked bond (SLB) further embeds Environmental Social Governance (ESG) targets into the core of Novartis business operations SLB linked to 2025 Patient Access...
NOVARTIS logo.jpg
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
September 01, 2020 01:00 ET | Novartis International AG
2025 target to increase patients reached in LMICs with strategic innovative medicines by 200% and the Novartis Flagship Programs by 50% - bringing potential reach to over 23 million patients across...
LogistiCare Partners with Liberty Resources to Deliver 75 Tons of Food to Disabled Philadelphia Residents In Need
August 20, 2020 11:34 ET | LogistiCare
Philadelphia, PA, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Philadelphia, P.A. – LogistiCare, the nation’s largest non-emergency medical transportation company, is partnering with Liberty Resources, Inc. to...
Sandoz
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
July 27, 2020 03:29 ET | Novartis International AG
Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe Planned combined investment of more than EUR 150 million...